![Paul W. K. Rothemund](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Paul W. K. Rothemund
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Palamedrix, Inc.
![]() Palamedrix, Inc. Miscellaneous Commercial ServicesCommercial Services Part of SomaLogic, Inc., Palamedrix, Inc. engages in leveraging DNA nanotechnology for revolutionary advancements in life science and medicine. The company is based in La Jolla, CA. The company was founded by Shane Bowen, Paul W. K. Rothemund, Ashwin Gopinath. Shane Bowen has been the CEO since incorporation. Palamedrix was acquired by SomaLogic, Inc. on September 30, 2022 for $52.50 million. | Hoofd Techniek/Wetenschap/O&O | - | - |
Oprichter | - | - |
Loopbaan van Paul W. K. Rothemund
Statistieken
Internationaal
Verenigde Staten | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoraal
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Palamedrix, Inc.
![]() Palamedrix, Inc. Miscellaneous Commercial ServicesCommercial Services Part of SomaLogic, Inc., Palamedrix, Inc. engages in leveraging DNA nanotechnology for revolutionary advancements in life science and medicine. The company is based in La Jolla, CA. The company was founded by Shane Bowen, Paul W. K. Rothemund, Ashwin Gopinath. Shane Bowen has been the CEO since incorporation. Palamedrix was acquired by SomaLogic, Inc. on September 30, 2022 for $52.50 million. | Commercial Services |